Kym Anthony, Chief Executive Officer at Avivagen, holds 100.00K shares in Avivagen (Ticker: TSE:VIV), holds ― shares in Liminal BioSciences (Ticker: LMNL). Most recently, Kym Anthony Bought ― shares of Avivagen on Jan 29, 2020 for an estimated value of 50.00K.